Hofseth BioCare ASA Discloses Key Shareholding Updates
Hofseth BioCare ASA, often referred to as HBC, has announced important developments regarding its shareholder structure, following a recent private placement of new shares. This significant event has impacted several shareholders, resulting in notable changes to their ownership percentages within the company.
Details of the Private Placement
On the date of the private placement's completion, certain shareholders received new shares, leading to their holdings surpassing the notifiable threshold. Among these shareholders was Guy Urquhart, who subscribed for a total of 55,444,444 new shares. Consequently, Urquhart’s total ownership now stands at 55,444,444 shares, equating to 12.21% of the company and representing the same percentage of voting rights at general meetings.
The Impact on Other Shareholders
In addition to Urquhart’s acquisition, several other shareholders have experienced changes to their holdings as a result of this share issuance. This private placement has led to a dilution of ownership for some existing shareholders.
Key Changes in Shareholder Ownership
After completing the first tranche of the private placement:
Funds managed by Bonafide Wealth Management have accumulated a total of 66,023,125 shares, which translates to 14.54% of the total ordinary shares and voting rights at shareholder meetings.
Aqua-Spark has increased its stake to 22,433,338 shares, amounting to 4.94% of the ordinary shares and corresponding voting rights.
Additionally, Yokorei Co. Ltd. holds 40,951,333 shares, indicating a 9.02% stake in the company and its voting power.
Regulatory Compliance and Disclosure Requirements
This disclosure is made to comply with regulations set forth under the Norwegian Securities Trading Act. The announcement fulfills the requirements specified in section 4-2 and keeps in line with section 5-12 of the same act.
Contact Information for Further Inquiry
For those looking for additional details regarding these updates, contact Jon Olav Ødegård, the CEO of Hofseth BioCare ASA. He can be reached at +47 936 32 966, and inquiries can be sent via email.
Frequently Asked Questions
What is the private placement mentioned in the announcement?
The private placement refers to the issuance of new shares in Hofseth BioCare ASA to existing and new shareholders, which affects ownership percentages.
Who are the main shareholders impacted by this private placement?
Main shareholders affected include Guy Urquhart, Bonafide Wealth Management, Aqua-Spark, and Yokorei Co. Ltd.
What percentage of shares does Guy Urquhart now own?
Guy Urquhart currently owns 12.21% of Hofseth BioCare ASA's total shares.
How does the private placement affect existing shareholders?
Existing shareholders may experience dilution of their ownership percentages due to the issuance of new shares.
Who should I contact for more information regarding these changes?
For additional inquiries, contact Jon Olav Ødegård, CEO of Hofseth BioCare ASA, via phone or email for further information.
